Meeting
2022 ASCO Genitourinary Cancers Symposium
Putative germline findings in tumor-only and liquid biopsy sequencing in veterans with aggressive prostate cancer.
Authors
Kara Noelle Maxwell
University of Pennsylvania, Philadelphia, PA
Kara Noelle Maxwell , Ryan Hausler , Isla Garraway , Nicholas George Nickols , Kyung Min Lee , Julie Ann Lynch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 179)
DOI
10.1200/JCO.2022.40.6_suppl.179
Abstract #
179
Poster Bd #
N12
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos